NCT03596632View on ClinicalTrials.gov

Study Investigating a Single Oral Dose of Fenebrutinib in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 27, 2018

Primary Completion Date

August 23, 2018

Study Completion Date

August 23, 2018

Conditions
Healthy Participants
Interventions
DRUG

Fenebrutinib

200-mg (100 µCi) oral solution 14C/12C\]-fenebrutinib

Trial Locations (1)

53704

Covance Clinical Research Unit, Inc, Madison

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03596632 - Study Investigating a Single Oral Dose of Fenebrutinib in Healthy Volunteers | Biotech Hunter | Biotech Hunter